Everest Medicines Ltd (HKSE:01952)
HK$ 36.3 3.8 (11.69%) Market Cap: 11.70 Bil Enterprise Value: 10.19 Bil PE Ratio: 0 PB Ratio: 2.46 GF Score: 40/100

Q2 2023 Everest Medicines Ltd Earnings Call (English) Transcript

Aug 24, 2023 / 01:00AM GMT
Release Date Price: HK$17.3 (-3.24%)
Operator

Good morning, and welcome to Everest Medicines 2023 Interim Results Conference Call. Please be advised that today's conference is being recorded. (Operator Instructions)

At this time, I would like to hand the conference over to your speaker today, Ms. Leah Liu, VP of Corporate Affairs. Please go ahead.

Leah Liu
Everest Medicines Limited - Joint Company Secretary & VP of Corporate Affairs

Thank you Operator. Good morning, everybody, and welcome to our 2023 interim financial results conference call. Joining us today are Mr. Rogers Luo, CEO of Everest Medicines. Mr. Ian Woo, President and CFO; Dr. Zhengying Zhu, our Chief Medical Officer; and Dr. Jennifer Yang, our Chief Scientific Officer.

Before we get started, I'd like to remind you that the speakers on this conference call may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the company or its officers with respect to business operations and financial conditions of the company, which can be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot